Evotec (ADR)
Combines discovery, development and biologics manufacturing for pharmaceutical and biotechnology partners.
$1.91
After-hours close−0.01 (−0.51%)
At close$1.92(−2.54%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 2.29%Insiders —
Shares outstanding 355.24M · Float 336.88M · 94.8% free float
Institutions13F, as of Mar 31, 2026
46 holders · 8.15M shares · 11 new positions · 22 increased · 14 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mubadala Investment Co PJSC | 4.60M | 1.29% | 0 | May 15, 2026 |
| DCF Advisers, LLC | 1.07M | 0.30% | −133.7K | May 11, 2026 |
| WCM Investment Management, LLC | 627.3K | 0.18% | +67.9K | May 7, 2026 |
| Abc Arbitrage SA | 509.1K | 0.14% | −45.2K | May 4, 2026 |
| Optiver Holding B.V. | 283.6K | 0.08% | +243.0K | Jun 2, 2026 |
| Morgan Stanley | 259.7K | 0.07% | +154 | May 15, 2026 |
| LPL Financial LLC | 122.3K | 0.03% | +27.7K | May 6, 2026 |
| Envestnet Asset Management Inc | 119.4K | 0.03% | +49.4K | May 4, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Triton GP HoldCo SARLincl. Excalibur LuxCo SARL, Triton Fund 6 SCSp +2 more | 9.99% | 17.73M | 13D | Oct 29, 2025 ↗ |
| MAK Capital One L.L.C.incl. Michael A. Kaufman, MAK Capital Fund LP | 7.10% | 12.68M | 13D | May 1, 2026 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.